EARLY BIRD DISCOUNT! Register by May 9, 2014 to receive 20% off your registration!
Register 3 for the price of 2 with the coupon code RCDVB!

 Overview | Speakers | Agenda | Poster Submissions | Venue | Sponsors 
Dear Colleague,

GTC is proud to present its Infectious Diseases World Summit 2014, to be held in Boston, MA on July 9-11, 2014. This summit will bring together experts from academia and industry to discuss cutting edge research and new technologies used in the pharmaceutical and biotech fields. It will also give global biotechnology and pharmaceutical companies an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, explore potential collaborations, and learn about relevant infectious diseases issues and deals that will affect the industry.

Registration to the conference will allow you unlimited access to the 3 tracks outlined below:

11th Anti-Infectives Partnering and Deal-Making

12th Vaccines Research & Development: All Things Considered
3rd Influenza Research & Development

Don't miss this opportunity - save these dates, mark your calendars and we'll see you in Boston!


Best regards,

2014 Conference Advisory Committee
 

2014 ADVISORY BOARD COMMITTEE

Anti-Infectives Partnering & Deal-Making:
Brent Ahrens, Canaan Partners
Richard Bax, TranScrip Partners
Shing Chang, Formerly DNDi
Kleem Chaudhary, Novartis
John Clerici, TiberCreek Partners
Danielle Drayton, Decision Resources
Barry Eisenstein, Cubist
Prabhavathi Fernandes, Cempra
Michael Gladstone, Atlas Venture
Peter Hammann , Sanofi-Aventis
Laurenz Kellenberger, Basilea Pharmaceutica
Joseph Larsen, BARDA
Eszter Nagy, Arsanis
Kush Parmar, 5AM Ventures
Manos Perros, AstraZeneca
John Rex, AstraZeneca
Aram Salzman, NovoBiotic
Joyce Sutcliffe, Tetraphase
Glenn Tillotson, TranScrip Partners
Philippe Villain-Guillot, Nosopharm

3rd Influenza Research & Development
Daniel Adams, Protein Sciences
Pamuk Bilsel, FluGen
Weisan Chen, La Trobe University
Dennis Christianson, Statens Serum Institut
Susan Ehrlich, Formerly NSABB
Michael Eisenbraun, Vaccine Research
Deborah Fuller, University of Washington
Rob Lambkin-Williams, Restroscreen
Robert Lenk, MediVector
Oliver Planz, University of Tuebingen
Lisa Purcell, Regeneron
Ram Sasisekharan, MIT
John Skehel, National Institute for Medical Research
Klaus Stohr, Novartis
Jonathan Yewdell, NIAID

Vaccines Research & Development: All Things Considered
Alan Barrett, University of Texas
Philip Dormitzer, Novartis
Jay Evans, GlaxoSmithKline
Joseph Joyce, Merck
Josef Kallen, Curevac
Rino Rappuoli, Novartis
Ken Rosenthal, Formerly NEOMED
Connie Schmaljohn, U.S. Army Medical Research Institute of Infectious Diseases
Angela Shen, United States Agency for International Development
Jeffrey Ulmer, Novartis
David Weiner, University of Pennsylvania
Dan Zimmerman, CEL-SCI

 

Attend ALL GTC Conferences for One Year for only $3,995 ($1,990 for Acad/Govt).
Click here to sign up!



 

GOLD SPONSORS